Clinical trial
Detecting EGFR T790M Mutations From Circulating Tumor Cells
NCT01734915 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Detecting EGFR T790M Mutations From Circulating Tumor Cells
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 30, 2012
- Completion date
- September 30, 2016
- Enrollment
- 40 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
non small cell lung cancer